Literature DB >> 12360433

Chronic renal dysfunction late after liver transplantation.

Ari J Cohen1, Mark D Stegall, Charles B Rosen, Russell H Wiesner, Nelson Leung, Walter K Kremers, Nizar N Zein.   

Abstract

With the increasing success of liver transplantation, more patients are developing late complications such as renal dysfunction. The goal of the current study was to assess the prevalence of renal dysfunction years after liver transplantation and to identify patients at risk for the development of this complication. Of the 527 liver transplantations performed at our institution between April 1990 and October 1998, 353 had pretransplantation and posttransplantation glomerular filtration rate (GFR) determinations by iothalamate clearance. From this entire group, 198 patients had actual 4-year follow-up and 52 had actual 6-year follow-up. In addition, 191 of these patients had intensive follow-up with GFR measurements pretransplantation and at 1 and 3 years posttransplantation (complete follow-up group). All patients received either tacrolimus- or cyclosporine-based immunosuppression. The overall mean GFR levels in both of these groups was acceptable and was not different in cyclosporine- versus tacrolimus-based immunosuppressive regimens. Renal dysfunction was progressive, with 27.5% of patients in the intensive group having a GFR < 40 mL/min/body surface area 5 years after transplantation. GFR pretransplantation did not correlate well with late renal function; however, GFR at 1 year identified patients with subsequent renal dysfunction. The cumulative incidence of renal failure for the entire group was 6.25% at 7 years and 10% at 10 years. Renal dysfunction is a major late complication after liver transplantation. The GFR at 1 year correlates best with late renal function. Patients with a low GFR at 1 year (< 40 mL/min/BSA) are a high-risk group that might benefit from early therapeutic interventions aimed at preventing subsequent renal failure.

Entities:  

Mesh:

Year:  2002        PMID: 12360433     DOI: 10.1053/jlts.2002.35668

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  18 in total

1.  Prophylaxis of chronic kidney disease after liver transplantation--experience from west China.

Authors:  Zhen-Yong Shao; Lu-Nan Yan; Wen-Tao Wang; Bo Li; Tian-Fu Wen; Jia-Yin Yang; Ming-Qing Xu; Ji-Chun Zhao; Yong-Gang Wei
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

Review 2.  Developments in liver transplantation.

Authors:  J Neuberger
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 3.  Liver transplantation for hepatitis C virus related liver disease.

Authors:  I Gee; G Alexander
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

Review 4.  Use of sirolimus in liver transplant recipients with renal insufficiency: a systematic review and meta-analysis.

Authors:  Sumeet K Asrani; Michael D Leise; Colin P West; M Hassan Murad; Rachel A Pedersen; Patricia J Erwin; Jianmin Tian; Russell H Wiesner; W Ray Kim
Journal:  Hepatology       Date:  2010-10       Impact factor: 17.425

Review 5.  Outcomes of liver transplantation in patients with hepatorenal syndrome.

Authors:  Rohan M Modi; Nishi Patel; Sherif N Metwally; Khalid Mumtaz
Journal:  World J Hepatol       Date:  2016-08-28

6.  Serum sodium, renal function, and survival of patients with end-stage liver disease.

Authors:  Young-Suk Lim; Timothy S Larson; Joanne T Benson; Patrick S Kamath; Walter K Kremers; Terry M Therneau; W Ray Kim
Journal:  J Hepatol       Date:  2010-02-04       Impact factor: 25.083

7.  Chronic kidney disease and associated mortality after liver transplantation--a time-dependent analysis using measured glomerular filtration rate.

Authors:  Alina M Allen; W Ray Kim; Terry M Therneau; Joseph J Larson; Julie K Heimbach; Andrew D Rule
Journal:  J Hepatol       Date:  2014-04-05       Impact factor: 25.083

8.  Daclizumab induction therapy in liver transplant recipients with renal insufficiency.

Authors:  S K Asrani; W R Kim; R A Pedersen; M R Charlton; W K Kremers; T M Therneau; C B Rosen; P G Dean
Journal:  Aliment Pharmacol Ther       Date:  2010-07-26       Impact factor: 8.171

9.  Microproteinuria for detecting calcineurin inhibitor-related nephrotoxicity after liver transplantation.

Authors:  Jing Li; Bin Liu; Lu-Nan Yan; Lan-Lan Wang; Wan Y Lau; Bo Li; Wen-Tao Wang; Ming-Qing Xu; Jia-Yin Yang; Fu-Gui Li
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

10.  Liver cell adenoma and liver cell adenomatosis.

Authors:  Ludger Barthelmes; Iain S Tait
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.